Alcohol consumption modulates host defense in rhesus macaques by altering gene expression in circulating leukocytes

Journal of Immunology

Volumn 196, Issue 1, 2016, Pages 182-195

  Barr, Tasha ^a   Girke, Thomas ^a   Sureshchandra, Suhas ^a   Nguyen, Christina ^a   Grant, Kathleen ^b   Messaoudi, Ilhem ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIBODY; MICRORNA; TRANSCRIPTOME; MESSENGER RNA; SMALLPOX VACCINE; VIRUS ANTIBODY;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOST RESISTANCE; IMMUNE RESPONSE; INFECTION; MALE; NEOPLASM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; PRIORITY JOURNAL; RHESUS MONKEY; UPREGULATION; WOUND HEALING; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE MODEL; DRINKING BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGY; T LYMPHOCYTE; VACCINATION; VACCINIA VIRUS;

ALCOHOL DRINKING; ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; ETHANOL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNITY, HUMORAL; LUNG DISEASES, OBSTRUCTIVE; MACACA MULATTA; MALE; MICRORNAS; NEOPLASMS; RNA, MESSENGER; SMALLPOX VACCINE; T-LYMPHOCYTES; VACCINATION; VACCINIA VIRUS; WOUND HEALING;

EID: 84953245599     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501527     Document Type: Article

References (165)

1. Bhattacharya, R., and M. C. Shuhart. 2003. Hepatitis C and alcohol: interactions, outcomes, and implications. J. Clin. Gastroenterol. 36: 242-252.
2. Happel, K. I., and S. Nelson. 2005. Alcohol, immunosuppression, and the lung. Proc. Am. Thorac. Soc. 2: 428-4132.
3. Nelson, S., and G. J. Bagby. 2011. Alcohol and HIV Infection. Trans. Am. Clin. Climatol. Assoc. 122: 244-253.
4. + immunodominant T cell responses following Listeria monocytogenes inoculation. J. Leukoc. Biol. 85: 34-43.
5. Mason, C. M., E. Dobard, R Zhang, and S. Nelson. 2004. Alcohol exacerbates murine pulmonary tuberculosis. Infect. Immun. 72: 2556-2563.
6. Meyerholz, D. K., M. Edsen-Moore, J. McGill, R. A. Coleman, R. T. Cook, and K. L. Legge. 2008. Chronic alcohol consumption increases the severity of murine influenza virus infections. J. Immunol. 181: 641-648.
7. Poonia, B., S. Nelson, G. J. Bagby, P Zhang, L. Quniton, and R. S. Veazey. 2006. Chronic alcohol consumption results in higher simian immunodeficiency virus replication in mucosally inoculated rhesus macaques. AIDS Res. Hum. Retroviruses 22: 589-594.
8. Curtis, B. J., A. Zahs, and E. J. Kovacs. 2013. Epigenetic targets for reversing immune defects caused by alcohol exposure. Alcohol Res. 35: 97-113.
9. Bode, C, and J. C. Bode. 2005. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol. Clin. Exp. Res. 29(11, Suppl.)166S-171S.
10. Szabo, G., and P Mandrekar. 2009. A recent perspective on alcohol, immunity, and host defense. Alcohol. Clin. Exp. Res. 33: 220-232.
11. Takkouche, B., C. Regueira-Mendez, R. Garcia-Closas, A. Figueiras, J. J. Gestal-Otero, and M. A. Hernan. 2002. Intake of wine, beer, and spirits and the risk of clinical common cold. Am. J. Epidemiol. 155: 853-858.
12. Cohen, S., D. A. Tyrrell, M. A. Russell, M. J. Jarvis, and A. P. Smith. 1993. Smoking, alcohol consumption, and susceptibility to the common cold. Am. J. Public Health 83: 1277-1283.
13. Ouchi, E., K. Niu, Y. Kobayashi, L. Guan, H. Momma, H. Guo, M. Chujo, A. Otomo, Y Cui, and R. Nagatomi. 2012. Frequent alcohol drinking is associated with lower prevalence of self-reported common cold: a retrospective study. BMC Public Health 12: 987.
14. Mendenhall, C. L., S. A. Theus, G. A. Roselle, C. J. Grossman, and S. D. Rouster. 1997. Biphasic in vivo immune function after low- versus high-dose alcohol consumption. Alcohol 14: 255-260.
15. Grant, K. A., X. Leng, H. L. Green, K. T Szeliga, L. S. Rogers, and S. W. Gonzales. 2008. Drinking typography established by scheduled induction predicts chronic heavy drinking in a monkey model of ethanol self-administration. Alcohol. Clin. Exp. Res. 32: 1824-1838.
16. Messaoudi, I., M. Asquith, F Engelmann, B. Park, M. Brown, A. Rau, J. Shaw, and K. A. Grant. 2013. Moderate alcohol consumption enhances vaccine-induced responses in rhesus macaques. Vaccine 32: 54-61.
17. Baker, E. J., J. Farro, S. Gonzales, C. Helms, and K. A. Grant. 2014. Chronic alcohol self-administration in monkeys shows long-term quantity/frequency categorical stability Alcohol. Clin. Exp. Res. 38: 2835-2843.
18. Huber, W., V. J. Carey, R. Gentleman, S. Anders, M. Carlson, B. S. Carvalho, H. C. Bravo, S. Davis, L. Gatto, T. Girke, et al. 2015. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods 12: 115-121.
19. Girke, T 2015. systemPipeR: NGS workflow and report generation environment. R package version 1.2.4 ed. Available at: https://github.com/tgirke/systemPipeR. Accessed: November 4, 2014.
20. Langmead, B., and S. L. Salzberg. 2012. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9: 357-359.
21. Kim, D., G. Pertea, C. Trapnell, H. Pimentel, R. Kelley, and S. L. Salzberg. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14: R36.
22. Cunningham, F, M. R. Amode, D. Barrell, K. Beal, K. Billis, S. Brent, D. Carvalho-Silva, P. Clapham, G. Coates, S. Fitzgerald, et al. 2015. Ensembl 2015. Nucleic Acids Res. 43: D662-D669.
23. Lawrence, M., W. Huber, H. Pages, P Aboyoun, M. Carlson, R. Gentleman, M. T Morgan, and V. J. Carey 2013. Software for computing and annotating genomic ranges. PLOS Comput. Biol. 9: el003118.
24. Robinson, M. D., D. J. McCarthy, and G. K. Smyth. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
25. Anders, S., D. J. McCarthy, Y. Chen, M. Okoniewski, G. K. Smyth, W. Huber, and M. D. Robinson. 2013. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat. Protoc. 8: 1765-1786.
26. Alexopoulou, A. N., H. A. Multhaupt, and J. R. Couchman. 2007. Syndecans in wound healing, inflammation and vascular biology Int. J. Biochem. Cell Biol. 39: 505-528.
27. Werner, S., and R. Grose. 2003. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83: 835-870.
28. Campbell, L., H. Williams, R. A. Crompton, S. M. Cruickshank, and M. J. Hardman. 2013. Nod2 deficiency impairs inflammatory and epithelial aspects of the cutaneous wound-healing response. J. Pathol. 229: 121-131.
29. Thomas, P. G., P. Dash, J. R. Aldridge, Jr., A. H. Ellebedy, C. Reynolds, A. J. Funk, W. J. Martin, M. Lamkanfi, R. J. Webby, K. L. Boyd, et al. 2009. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30: 566-575.
30. DiScipio, R. G., P. J. Daffern, M. A. Jagels, D. H. Broide, and P Sriramarao. 1999. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J. Immunol. 162: 1127-1136.
31. Schroder, W. A., L. Major, and A. Suhrbier. 2011. The role of SerpinB2 in immunity. Crit. Rev. Immunol. 31: 15-30.
32. Herrera, I., J. Cisneros, M. Maldonado, R. Ramirez, B. Ortiz-Quintero, E. Anso, N. S. Chandel, M. Selman, and A. Pardo. 2013. Matrix metal-loproteinase (MMP)-l induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption. J. Biol. Chem. 288: 25964-25975.
33. Kasahara, Y., R. M. Tuder, C. D. Cool, D. A. Lynch, S. C. Flores, and N. F. Voelkel. 2001. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 163: 737-744.
34. Rico de Souza, A., M. Zago, S. J. Pollock, P. J. Sime, R. P. Phipps, and C. J. Baglole. 2011. Genetic ablation of the aryl hydrocarbon receptor causes cigarette smoke-induced mitochondrial dysfunction and apoptosis. J. Biol. Chem. 286: 43214-43228.
35. Wang, C. Y., and C. F. Lin. 2014. Annexin A2: its molecular regulation and cellular expression in cancer development. Dis. Markers 2014: 308976.
36. Kuramochi, H., G. Nakajima, Y. Kaneko, A. Nakamura, Y. Inoue, M. Yamamoto, and K. Hayashi. 2012. Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases. BMC Cancer 12: 88.
37. Bouchon, A., F. Facchetti, M. A. Weigand, and M. Colonna. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103-1107.
38. Radulescu, A., X. Yu, N. D. Orvets, Y. Chen, H. Y. Zhang, and G. E. Besner. 2010. Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis. J. Pediatr. Surg. 45: 729-734.
39. Wang, Z. Q., W. M. Xing, H. H. Fan, K. S. Wang, H. K. Zhang, Q. W. Wang, J. Qi, H. M. Yang, J. Yang, Y. N. Ren, et al. 2009. The novel lipopolysaccharide-binding protein CRISPLD2 is a critical serum protein to regulate endotoxin function. J. Immunol. 183: 6646-6656.
40. Abramovici, H., P. Mojtabaie, R. J. Parks, X. P. Zhong, G. A. Koretzky, M. K. Topham, and S. H. Gee. 2009. Diacylglycerol kinase zeta regulates actin cytoskeleton reorganization through dissociation of Racl from RhoGDI. Mol. Biol. Cell 20: 2049-2059.
41. Xiang, Y, Y. R. Tan, J. S. Zhang, X. Q. Qin, B. B. Hu, Y. Wang, F. Qu, and H. J. Liu. 2008. Wound repair and proliferation of bronchial epithelial cells regulated by CTNNAL1. J. Cell. Biochem. 103: 920-930.
42. Gill, S. E., and W. C. Parks. 2008. Metalloproteinases and their inhibitors: regulators of wound healing. Int. J. Biochem. Cell Biol. 40: 1334-1347.
43. Thuraisingam, T., H. Sam, J. Moisan, Y. Zhang, A. Ding, and D. Radzioch. 2006. Delayed cutaneous wound healing in mice lacking solute carrier llal (formerly Nrampl): correlation with decreased expression of secretory leukocyte protease inhibitor. J. Invest. Dermatol. 126: 890-901.
44. Okuno, Y, A. Nakamura-Ishizu, K. Kishi, T. Suda, and Y. Kubota. 2011. Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing. Blood 117: 5264-5272.
45. Malik, A, and J. K. Batra. 2012. Antimicrobial activity of human eosinophil granule proteins: involvement in host defence against pathogens. Crit. Rev. Microbiol. 38: 168-181.
46. Li, J., Y. Fu, B. Zhao, Y. Xiao, and R. Chen. 2014. Myeloperoxidase G463A polymorphism and risk of lung cancer. Tumour Biol. 35: 821-829.
47. Albrechtsen, R., M. Kveiborg, D. Stautz, J. Vikesa, J. B. Noer, A. Kotzsh, F. C. Nielsen, U. M. Wewer, and C. Frohlich. 2013. ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth. J. Cell Sci. 126: 4707-4720.
48. van Vliet, S. J., E. Saeland, and Y. van Kooyk. 2008. Sweet preferences of MGL: carbohydrate specificity and function. Trends Immunol. 29: 83-90.
49. Procko, E., and R. Gaudet. 2009. Antigen processing and presentation: TAP-ping into ABC transporters. Curr. Opin. Immunol. 21: 84-91.
50. Legrand, F, N. Tomasevic, O. Simakova, C. C. Lee, Z. Wang, M. Raffeld, M. A. Makiya, V. Palath, J. Leung, M. Baer, et al. 2014. The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders. J. Allergy Clin Immunol 133: 1439-1447, 1447.el-8.
51. Zhao, H., W. Yang, R. Qiu, J. Li, Q. Xin, X. Wang, Y. Feng, S. Shan, Y. Liu, Y. Gong, and Q. Liu. 2012. An intronic variant associated with systemic lupus erythematosus changes the binding affinity of Yinyangl to downregulate WDFY4. Genes Immun. 13: 536-542.
52. Perry, R. T., D. A. Gearhart, H. W. Wiener, L. E. Harrell, J. C. Barton, A. Kutlar, F. Kutlar, O. Ozcan, R. C. Go, and W. D. Hill. 2008. Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease. Neurobiol. Aging 29: 185-193.
53. Takaki, S., H. Morita, Y. Tezuka, and K. Takatsu. 2002. Enhanced hemato-poiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J. Exp. Med. 195: 151-160.
54. Voehringer, D., M. Koschella, and H. Pircher. 2002. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor Gl (KLRG1). Blood 100: 3698-3702.
55. Murray, C. M., R. Hutchinson, J. R. Bantick, G. P. Belfield, A. D. Benjamin, D. Brazma, R. V. Bundick, I. D. Cook, R. I. Craggs, S. Edwards, et al. 2005. Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat. Chem. Biol. 1: 371-376.
56. Zhu, Y. X., S. Benn, Z. H. Li, E. Wei, E. Masih-Khan, Y. Trieu, M. Bali, C. J. McGlade, J. O. Claudio, and A. K. Stewart. 2004. The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades. J. Exp. Med. 200: 737-747.
57. + T cell longevity in vivo. J. Immunol. 179: 4550-4562.
58. Metzger, M. L., I. Michelfelder, S. Goldacker, K. Melkaoui, J. Litzman, D. Guzman, B. Grimbacher, and U. Salzer. 2015. Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis. Clin. Exp. Immunol. 179: 256-264.
59. Vogler, M. 2012. BCL2A1: the underdog in the BCL2 family. Cell Death Differ. 19: 67-74.
60. Franzoso, G., L. Carlson, T. Scharton-Kersten, E. W. Shores, S. Epstein, A. Grinberg, T. Tran, E. Shacter, A. Leonardi, M. Anver, et al. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 6: 479-4490.
61. Fukuda, T., T. Yoshida, S. Okada, M. Hatano, T. Miki, K. Ishibashi, S. Okabe, H. Koseki, S. Hirosawa, M. Taniguchi, et al. 1997. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186: 439-4448.
62. Cao, Z., A. K. Wara, B. Icli, X. Sun, R. R. Packard, F. Esen, C. J. Stapleton, M. Subramaniam, K. Kretschmer, I. Apostolou, et al. 2009. Kruppel-like factor KLF10 targets transforming growth factor-betal to regulate CD4(+)CD25(-) T cells and T regulatory cells. J. Biol. Chem. 284: 24914-24924.
63. Ali, S., A. F. Hirschfeld, M. L. Mayer, E. S. Fortuno, III, N. Corbett, M. Kaplan, S. Wang, J. Schneiderman, C. D. Fjell, J. Yan, et al. 2013. Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia. J. Immunol. 190: 3949-3958.
64. Milkiewicz, M., C. Uchida, E. Gee, T. Fudalewski, and T. L. Haas. 2008. Shear stress-induced Ets-1 modulates protease inhibitor expression in microvascular endothelial cells. J. Cell. Physiol. 211: 502-510.
65. Ju, S., Y. Zhu, L. Liu, S. Dai, C. Li, E. Chen, Y. He, X. Zhang, and B. Lu. 2009. Gadd45b and Gadd45g are important for anti-tumor immune responses. Eur. J. Immunol. 39: 3010-3018.
66. Chau, C. H., C. A. Clavijo, H. T. Deng, Q. Zhang, K. J. Kim, Y. Qiu, A. D. Le, and D. K. Ann. 2005. Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systems. Am. J. Physiol. Cell Physiol. 289: C444-C454.
67. Suomela, S., L. Cao, A. Bowcock, and U. Saarialho-Kere. 2004. Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers. J. Invest. Dermatol. 122: 717-721.
68. Schaal, U., S. Grenz, S. Merkel, T. T. Rau, M. V. Hadjihannas, E. Kremmer, P. Chudasama, R. S. Croner, J. Behrens, M. Sturzl, and E. Naschberger. 2013. Expression and localization of axin 2 in colorectal carcinoma and its clinical implication. Int. J. Colorectal Dis. 28: 1469-1478.
69. Walther, N., A. Ulrich, M. Vockerodt, F. von Bonin, W. Klapper, K. Meyer, S. Eberth, T. Pukrop, R. Spang, L. Trumper, and D. Kube. 2013. Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma. Am. J. Pathol. 182: 1092-1098.
70. Wang, Q. F, Y. J. Li, J. F. Dong, B. Li, J. J. Kaberlein, L. Zhang, F. E. Arimura, R. T. Luo, J. Ni, F. He, et al. 2014. Regulation of MEIS1 by distal enhancer elements in acute leukemia. Leukemia 28: 138-146.
71. Ding, L., C. Niu, Y. Zheng, Z. Xiong, Y. Liu, J. Lin, H. Sun, K. Huang, W. Yang, X. Li, and Q. Ye. 2011. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth. J. Cell. Mol. Med. 15: 72-85.
72. Alliey-Rodriguez, N., D. Zhang, J. A. Badner, B. B. Lahey, X. Zhang, S. Dinwiddie, B. Romanos, N. Plenys, C. Liu, and E. S. Gershon. 2011. Genome-wide association study of personality traits in bipolar patients. Psy-chiatr. Genet. 21: 190-194.
73. Hansen, C. G., N. A. Bright, G. Howard, and B. J. Nichols. 2009. SDPR induces membrane curvature and functions in the formation of caveolae. Nat. Cell Biol. 11: 807-814.
74. Laurent, B., V. Randrianarison-Huetz, Z. Kadri, P. H. Romeo, F. Porteu, and D. Dumenil. 2009. Gfi-IB promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells. Stem Cells 27: 2153-2162.
75. Yowe, D., N. Weich, M. Prabhudas, L. Poisson, P. Errada, R. Kapeller, K. Yu, L. Faron, M. Shen, J. Cleary, et al. 2001. RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes. Biochem. J. 359: 109-118.
76. Mori, R., K. T. Power, C. M. Wang, P. Martin, and D. L. Becker. 2006. Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J. Cell Sci. 119: 5193-5203.
77. Poutahidis, T., S. M. Kearney, T. Levkovich, P. Qi, B. J. Varian, J. R. Lakritz, Y. M. Ibrahim, A. Chatzigiagkos, E. J. Aim, and S. E. Erdman. 2013. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One 8: e78898.
78. Dressier, J., L. Bachmann, R. Koch, and E. Miiller. 1999. Enhanced expression of selectins in human skin wounds. Int. J. Legal Med. 112: 39-444.
79. Liu, C, Y. Wei, J. Wang, L. Pi, J. Huang, and P. Wang. 2012. Carbonic anhydrases IE and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure. Clin. Dev. Immunol. 2012: 354594.
80. Yamashita, Y, K. Naitoh, H. Wada, M. Ikejiri, T. Mastumoto, K. Ohishi, Y. Hosaka, M. Nishikawa, and N. Katayama. 2014. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy. Thromb. Res. 133: 440-444.
81. Knight, W., and C. Yan. 2013. Therapeutic potential of PDE modulation in treating heart disease. Future Med. Chem. 5: 1607-1620.
82. Voora, D., D. Cyr, J. Lucas, J. T. Chi, J. Dungan, T. A. McCaffrey, R. Katz, L. K. Newby, W. E. Kraus, R. C. Becker, et al. 2013. Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events. J. Am. Coll. Cardiol. 62: 1267-1276.
83. Dalai, M. D., C. W. Morgans, R. M. Duvoisin, E. A. Gamboa, B. G. Jeffrey, S. J. Garg, C. C. Chan, and H. N. Sen. 2013. Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach. Ophthalmology 120: 2560-2564.
84. Sugiura, T., and K. Miyamoto. 2008. Characterization of TRJJVBl, upregulated in gastric adenocarcinoma, as anovel RBCC protein. J. Cell. Biochem. 105: 1081-1091.
85. Soini, Y., M. Eskelinen, R Juvonen, V. Karja, K. M. Haapasaari, A. Saarela, and P. Karihtala. 2014. Strong claudin 5 expression is a poor prognostic sign in pancreatic adenocarcinoma. Tumour Biol. 35: 3803-3808.
86. Yanai, H., K. Nakamura, S. Hijioka, A. Kamei, T. Ikari, Y. Ishikawa, E. Shinozaki, N. Mizunuma, K. Hatake, and A. Miyajima. 2010. Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency. J. Biochem. 148: 85-92.
87. Reuveni, H., E. Flashner-Abramson, L. Steiner, K. Makedonski, R. Song, A. Shir, M. Herlyn, M. Bar-Eli, and A. Levitzki. 2013. Therapeutic destruction of insulin receptor substrates for cancer treatment. Cancer Res. 73: 4383-44394.
88. Berger, M. E, E. Hodis, T. P. Heffernan, Y. L. Deribe, M. S. Lawrence, A. Protopopov, E. Ivanova, I. R. Watson, E. Nickerson, P. Ghosh, et al. 2012. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485: 502-506.
89. da Costa, A. N., A. Plymoth, D. Santos-Silva, S. Ortiz-Cuaran, S. Carney, P. Guilloreau, S. Sangrajrang, T. Khuhaprema, M. Mendy, O. A. Lesi, et al. 2015. Osteopontin and latent-TGF p binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. Int. J. Cancer. 136: 172-181.
90. Naba, A., K. R. Clauser, J. M. Lamar, S. A. Carr, and R. O. Hynes. 2014. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. eLife 3: e01308.
91. Australian Ovarian Cancer Study Group/Australian Cancer Study (Ovarian Cancer)Ovarian Cancer Association Consortium. 2011. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int. J. Cancer 128: 2063-2074.
92. + and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 260: 355-358.
93. Morris, M. A., and K. Ley. 2004. Trafficking of natural killer cells. Curr. Mol. Med. 4: 431-438.
94. Rodriguez-Grande, B., M. Swana, L. Nguyen, P. Englezou, S. Maysami, S. M. Allan, N. J. Rothwell, C. Garlanda, A. Denes, and E. Pinteaux. 2014. The acute-phase protein PTX3 is an essential mediator of glial scar formation and resolution of brain edema after ischemic injury. J. Cereb. Blood Flow Metab. 34: 480-4488.
95. Banha, J., L. Marques, R. Oliveira, Mde. F. Martins, E. Paixao, D. Pereira, R. Malho, D. Penque, and L. Costa. 2008. Ceruloplasmin expression by human peripheral blood lymphocytes: a new link between immunity and iron metabolism. Free Radic. Biol. Med. 44: 483-492.
96. Johnson, B. J., E. O. Costelloe, D. R. Fitzpatrick, J. B. Haanen, T. N. Schumacher, L. E. Brown, and A. Kelso. 2003. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc. Natl. Acad. Set USA 100: 2657-2662.
97. Djavani, M. M., O. R. Crasta, J. C. Zapata, Z. Fei, O. Folkerts, B. Sobral, M. Swindells, J. Bryant, H. Davis, C. D. Pauza, et al. 2007. Early blood profiles of virus infection in a monkey model for Lassa fever. J. Virol. 81: 7960-7973.
98. Faber, J., H. Kantarjian, M. W. Roberts, M. Keating, E. Freireich, and M. Albitar. 2000. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia. Arch. Pathol. Lab. Med. 124: 92-97.
99. Huang, H., X. Jiang, Z. Li, Y. Li, C. X. Song, C. He, M. Sun, P. Chen, S. Gurbuxani, J. Wang, et al. 2013. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc. Natl. Acad. Sci. USA 110: 11994-11999.
100. D'Angelo, V., G. Pecoraro, P. Indolfi, A. Iannotta, V. Donofrio, M. E. Errico, C. Indolfi, M. Ramaglia, A. Lombardi, M. Di Martino, et al. 2014. Expression and localization of serine protease Htral in neuroblastoma: correlation with cellular differentiation grade. J. Neurooncol. 117: 287-294.
101. Ng, K. T., C. M. Lo, D. Y. Guo, X. Qi, C. X. Li, W. Geng, X. B. Liu, C. C. Ling, Y. Y. Ma, W. H. Yeung, et al. 2014. Identification of transmembrane protein 98 as a novel chemoresistance-conferring gene in hepatocellular carcinoma. Mol. Cancer Ther. 13: 1285-1297.
102. Lotfi, A., G. Mohammadi, A. Tavassoli, M. Mousaviagdas, H. Chavoshi, and L. Saniee. 2015. Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma. Asian Pac. J. Cancer Prev. 16: 1327-1330.
103. Tomankova, T, M. Petrek, J. Gallo, and E. Kriegova. 2012. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases. Scand. J. Immunol. 75: 129-141.
104. Shukla, S. D., and R. W. Lim. 2013. Epigenetic effects of ethanol on the liver and gastrointestinal system. Alcohol Res. 35: 47-55.
105. Bufe, B., T. Schumann, R. Kappl, I. Bogeski, C. Kummerow, M. Podgorska, S. Smola, M. Hoth, and F. Zufall. 2015. Recognition of bacterial signal peptides by mammalian formyl peptide receptors: a new mechanism for sensing pathogens. J. Biol. Chem. 290: 7369-7387.
106. Tsou, C. L., W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian, S. P. Weisberg, M. Mack, and I. F. Charo. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117: 902-909.
107. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195-3204.
108. Howard, O. M., J. A. Turpin, R. Goldman, and W. S. Modi. 2004. Functional redundancy of the human CCL4 and CCL4L1 chemokine genes. Biochem. Biophys. Res. Commun. 320: 927-931.
109. Narumi, K., R. Miyakawa, R. Ueda, H. Hashimoto, Y. Yamamoto, T. Yoshida, and K. Aoki. 2015. Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE. J. Immunol. 194: 5539-5548.
110. Beech, R. D., J. Qu, J. J. Leffert, A. Lin, K. A. Hong, J. Hansen, S. Umlauf, S. Mane, H. Zhao, and R. Sinha. 2012. Altered expression of cytokine signaling pathway genes in peripheral blood cells of alcohol dependent subjects: preliminary findings. Alcohol. Clin. Exp. Res. 36: 1487-1496.
111. Joosten, M. M., M. J. van Erk, L. Pellis, R. F. Witkamp, and H. F. Hendriks. 2012. Moderate alcohol consumption alters both leucocyte gene expression profiles and circulating proteins related to immune response and lipid metabolism in men. Br. J. Nutr. 108: 620-627.
112. Querec, T. D., R. S. Akondy, E. K. Lee, W. Cao, H. I. Nakaya, D. Teuwen, A. Pirani, K. Gernert, J. Deng, B. Marzolf, et al. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10: 116-125.
113. Gaucher, D., R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher, A. Filali-Mouhim, J. M. Moser, R. S. Mehta, D. R. Drake, III, E. Castro, et al. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205: 3119-3131.
114. Greiffenstein, P., and P. E. Molina. 2008. Alcohol-induced alterations on host defense after traumatic injury. J. Trauma 64: 230-240.
115. Choudhry, M. A., and I. H. Chaudry. 2006. Alcohol intoxication and post-burn complications. Front. Biosci. 11: 998-1005.
116. Radek, K. A., E. J. Kovacs, R. L. Gallo, and L. A. DiPietro. 2008. Acute ethanol exposure disrupts VEGF receptor cell signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 295: H174-H184.
117. Cherpitel, C. J. 2013. Focus on: the burden of alcohol use-trauma and emergency outcomes. Alcohol Res. 35: 150-154.
118. Raimondi, C, A. Fantin, A. Lampropoulou, L. Denti, A. Chikh, and C. Ruhrberg. 2014. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells. J. Exp. Med. 211: 1167-1183.
119. Caddy, J., T. Wilanowski, C. Darido, S. Dworkin, S. B. Ting, Q. Zhao, G. Rank, A. Auden, S. Srivastava, T. A. Papenfuss, et al. 2010. Epidermal wound repair is regulated by the planar cell polarity signaling pathway. Dev. Cell 19: 138-147.
120. To, W. S., and K. S. Midwood. 2011. Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair 4: 21.
121. Gu, Q., D. Wang, Y. Gao, J. Zhou, R. Peng, Y. Cui, G. Xia, Q. Qing, H. Yang, J. Liu, and M. Zhao. 2002. Expression of MMP1 in surgical and radiation-impaired wound healing and its effects on the healing process. J. Environ. Pathol. Toxicol. Oncol. 21: 71-78.
122. Tokunaga, F, T. Nakagawa, M. Nakahara, Y. Saeki, M. Taniguchi, S. Sakata, K. Tanaka, H. Nakano, and K. Iwai. 2011. SHARPIN is a component of the NF-KB-activating linear ubiquitin chain assembly complex. Nature 471: 633-636.
123. Hirayama, F, A. H. Lee, C. W. Binns, T. Oga, and K. Nishimura. 2008. Alcohol consumption in patients with chronic obstructive pulmonary disease in Japan. Asia Pac. J. Public Health 20(Suppl.): 87-94.
124. Tabak, C, H. A. Smit, L. Rasanen, F. Fidanza, A. Menotti, A. Nissinen, E. J. Feskens, D. Heederik, and D. Kromhout. 2001. Alcohol consumption in relation to 20-year COPD mortality and pulmonary function in middle-aged men from three European countries. Epidemiology 12: 239-245.
125. Joshi, P. C, and D. M. Guidot. 2007. The alcoholic lung: epidemiology, pathophysiology, and potential therapies. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L813-L823.
126. Prout, M., G. S. Martin, K. Drexler, L. A. Brown, and D. M. Guidot. 2007. Alcohol abuse and acute lung injury: can we target therapy? Expert Rev. Respir. Med. 1: 197-207.
127. Clark, B. J., A. Williams, L. M. Feemster, K. A. Bradley, M. Macht, M. Moss, and E. L. Burnham, NHLBI ARDS Network Investigators. 2013. Alcohol screening scores and 90-day outcomes in patients with acute lung injury. Crit. Care Med. 41: 1518-1525.
128. Kaphalia, L., and W. J. Calhoun. 2013. Alcoholic lung injury: metabolic, biochemical and immunological aspects. Toxicol. Lett. 222: 171-179.
129. Tilley, S. L., M. Jaradat, C. Stapleton, D. Dixon, X. Hua, C. J. Erikson, J. G. McCaskill, K. D. Chason, G. Liao, L. Jania, et al. 2007. Retinoid-related orphan receptor gamma controls immunoglobulin production and Thl/Th2 cytokine balance in the adaptive immune response to allergen. J. Immunol. 178: 3208-3218.
130. Gao, Y, X. D. Xue, J. Y. Li, and N. Wang. 2007. [Expression and roles of CDK4 and p21 in lung tissues of premature rats with hyperoxia-induced chronic lung disease]. Zhongguo Dang Dai Er Ke Za Zhi 9: 595-600.
131. Hermesh, T, T. M. Moran, D. Jain, and C. B. Lopez. 2012. Granulocyte colony-stimulating factor protects mice during respiratory virus infections. PLoS One 7: e37334.
132. Song, Y. S., E. M. Yang, S. H. Kim, H. J. Jin, and H. S. Park. 2012. Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease. Int. Arch. Allergy Immunol. 159: 157-161.
133. Klesney-Tait, J., K. Keck, X. Li, S. Gilfillan, K. Otero, S. Baruah, D. K. Meyerholz, S. M. Varga, C. J. Knudson, T. O. Moninger, et al. 2013. Trans epithelial migration of neutrophils into the lung requires TREM-1. J. Clin. Invest. 123: 138-149.
134. Koh, W. J., O. J. Kwon, E. J. Kim, K. S. Lee, C. S. Ki, and J. W. Kim. 2005. NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 128: 94-101.
135. Tang, K., H. B. Rossiter, P. D. Wagner, and E. C. Breen. 2004. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J. Appl. Physiol. 97: 1559-1566, discussion 1549.
136. O'Keefe, J. H., S. K. Bhatti, A. Bajwa, J. J. DiNicolantonio, and C. J. Lavie. 2014. Alcohol and cardiovascular health: the dose makes the poison. or the remedy. Mayo Clin. Proc. 89: 382-393.
137. Ikehara, S., H. Iso, K. Yamagishi, Y. Kokubo, I. Saito, H. Yatsuya, M. Inoue, and S. Tsugane, JPHC Study Group. 2013. Alcohol consumption and risk of stroke and coronary heart disease among Japanese women: the Japan Public Health Center-based prospective study. Prev. Med. 57: 505-510.
138. Spiel, A. O., J. C. Gilbert, and B. Jilma. 2008. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation 117: 1449-1459.
139. Mays, T. A, P. F. Binkley, A. Lesinski, A. A. Doshi, M. P. Quaile, K. B. Margulies, P. M. Janssen, and J. A. Rafael-Fortney. 2008. Claudin-5 levels are reduced in human end-stage cardiomyopathy. J. Mol. Cell. Cardiol. 45: 81-87.
140. Baan, R., K. Straif, Y. Grosse, B. Secretan, F. El Ghissassi, V. Bouvard, A. Altieri, and V. Cogliano, WHO International Agency for Research on Cancer Monograph Working Group. 2007. Carcinogenicity of alcoholic beverages. Lancet Oncol. 8: 292-293.
141. Grewal, P., and V. A. Viswanathen. 2012. Liver cancer and alcohol. Clin. Liver Dis. 16: 839-850.
142. Fedirko, V., I. Tramacere, V. Bagnardi, M. Rota, L. Scotti, F. Islami, E. Negri, K. Straif, I. Romieu, C. La Vecchia, et al. 2011. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann. Oncol. 22: 1958-1972.
143. Rocha, R. L., S. G. Hilsenbeck, J. G. Jackson, C. L. VanDenBerg, Cn. Weng, A. V. Lee, and D. Yee. 1997. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin. Cancer Res. 3: 103-109.
144. Cantarini, M. C, S. M. de la Monte, M. Pang, M. Tong, A. D'Errico, F. Trevisani, and J. R. Wands. 2006. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology 44: 446-457.
145. Ravikumar, S., G. Perez-Liz, L. Del Vale, D. R. Soprano, and K. J. Soprano. 2007. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. Cancer Res. 67: 9266-9275.
146. Esposito, D. L., F. Aru, R. Lattanzio, A. Morgano, M. Abbondanza, R. Malekzadeh, F. Bishehsari, R. Valanzano, A. Russo, M. Piantelli, et al. 2012. The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. PLoS One 7: e36190.
147. Shelton, D. N., H. Fornalik, T. Neff, S. Y. Park, D. Bender, K. DeGeest, X. Liu, W. Xie, D. K. Meyerholz, J. F. Engelhardt, and M. J. Goodheart. 2012. The role of LEF1 in endometrial gland formation and carcinogenesis. PLoS One 1: e40312.
148. Wu, L., J. C. Zhao, J. Kim, H. J. Jin, C. Y. Wang, and J. Yu. 2013. ERG is a critical regulator of Wnt/LEFl signaling in prostate cancer. Cancer Res. 73: 6068-6079.
149. Wang, W. J., Y. Yao, L. L. Jiang, T. H. Hu, J. Q. Ma, Z. J. Liao, J. T. Yao, D. F. Li, S. H. Wang, and K. J. Nan. 2013. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo. PLoS One 8: e76596.
150. Lee, J. E., D. J. Hunter, D. Spiegelman, H. O. Adami, D. Albanes, L. Bernstein, P. A. van den Brandt, J. E. Buring, E. Cho, A. R. Folsom, et al. 2007. Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J. Natl. Cancer Inst. 99: 801-810.
151. Gorini, G., E. Stagnaro, V. Fontana, L. Miligi, V. Ramazzotti, D. Amadori, S. Rodella, R. Tumino, P. Crosignani, C. Vindigni, et al. 2007. Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study. Ann. Oncol. 18: 143-148.
152. Allen, N. E., V. Beral, D. Casabonne, S. W. Kan, G. K. Reeves, A. Brown, and J. Green, Million Women Study Collaborators. 2009. Moderate alcohol intake and cancer incidence in women. J. Natl. Cancer Inst. 101: 296-305.
153. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10: 111-122.
154. Lim, L., A. Balakrishnan, N. Huskey, K. D. Jones, M. Jodari, R. Ng, G. Song, J. Riordan, B. Anderton, S. T. Cheung, et al. 2014. MicroRNA-494 within an oncogenic microRNA megacluster regulates Gl/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer. Hepatology 59: 202-215.
155. Li, P., Q. Xu, D. Zhang, X. Li, L. Han, J. Lei, W. Duan, Q. Ma, Z. Wu, and Z. Wang. 2014. Upregulated miR-106a plays an oncogenic role in pancreatic cancer. FEBS Lett. 588: 705-712.
156. Meng, F, S. S. Glaser, H. Francis, F. Yang, Y. Han, A. Stokes, D. Staloch, J. McCarra, J. Liu, J. Venter, et al. 2012. Epigenetic regulation of miR-34a expression in alcoholic liver injury. Am. J. Pathol. 181: 804-817.
157. Asquith, M., S. Pasala, F. Engelmann, K. Haberthur, C. Meyer, B. Park, K. A. Grant, and I. Messaoudi. 2014. Chronic ethanol consumption modulates growth factor release, mucosal cytokine production, and microRNA expression in nonhuman primates. Alcohol. Clin. Exp. Res. 38: 980-993.
158. Tili, E., J. J. Michaille, A. Cimino, S. Costinean, C. D. Dumitru, B. Adair, M. Fabbri, H. Alder, C. G. Liu, G. A. Calin, and C. M. Croce. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179: 5082-5089.
159. Shi, L., B. Fisslthaler, N. Zippel, T. Fromel, J. Hu, A. Elgheznawy, H. Heide, R. Popp, and I. Fleming. 2013. MicroRNA-223 antagonizes angiogenesis by targeting pi integrin and preventing growth factor signaling in endothelial cells. Circ. Res. 113: 1320-1330.
160. Haneklaus, M., M. Gerlic, L. A. O'Neill, and S. L. Masters. 2013. miR-223: infection, inflammation and cancer. J. Intern. Med. 274: 215-226.
161. Raisch, J., A. Darfeuille-Michaud, and H. T. Nguyen. 2013. Role of microRNAs in the immune system, inflammation and cancer. World J. Gastroenterol. 19: 2985-2996.
162. Chen, S., P. Li, J. Li, Y. Wang, Y. Du, X. Chen, W. Zang, H. Wang, H. Chu, G. Zhao, and G. Zhang. 2015. MiR-144 inhibits proliferation and induces ap-optosis and autophagy in lung cancer cells by targeting TIGAR. Cell. Physiol. Biochem. 35: 997-1007.
163. Dolganiuc, A., J. Petrasek, K. Kodys, D. Catalano, P. Mandrekar, A. Velayudham, and G. Szabo. 2009. MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol. Clin. Exp. Res. 33: 1704-1710.
164. Zhang, C, Q. Wang, X. Xi, J. Jiao, W. Xu, J. Huang, and Z. Lai. 2015. High serum miR-183 level is associated with the bioactivity of macrophage derived from tuberculosis patients. Int. J. Clin. Exp. Pathol. 8: 655-659.
165. Primo, M. N., R. O. Bak, B. Schibler, and J. G. Mikkelsen. 2012. Regulation of pro-inflammatory cytokines TNFa and IL24 by microRNA-203 in primary keratinocytes. Cytokine 60: 741-748.